Medications

Patients may become immune to botulinum toxin treatments

(HealthDay)—About 15 percent of patients treated with botulinum toxin type A (BoNT/A) for dystonia or spasticity can develop an immune response to the treatment itself, according to a study published online Nov. 21 in Neurology.

Diseases, Conditions, Syndromes

Researchers discover potential antidote to botulism

Researchers have identified a compound that strongly inhibits botulinum neurotoxin, the most toxic compound known. That inhibiting compound, nitrophenyl psoralen (NPP), could be used as a treatment to reduce paralysis induced ...

Sports Medicine & Kinesiology

Study finds tennis elbow treatments provide little to no benefit

The painful condition known as "tennis elbow" results from overuse of the tendons in the forearm, typically in a patient's dominant arm. A repetitive stress injury, tennis elbow affects not just athletes, but also tradesmen, ...

Health

Facial exercise speeds Botox's wrinkle-reducing effects

For people who can't wait the three or four days for the wrinkle smoothing effects of botulinum toxin (Botox) injections to kick in, a new Northwestern Medicine study shows facial exercise after the injections speeds the ...

Medications

Novel botulinum toxin compound relieves chronic pain

A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to research by UCL, ...

Surgery

Botulinum toxin injections improve facial surgical scars

(HealthDay)—Botulinum toxin injections in surgical wound closure immediately after surgery improve facial surgery scars, according to a small study published in the March issue of Plastic and Reconstructive Surgery.

page 1 from 7